聚合物混合物控制纳米颗粒的表面电荷,改善粘液透和上皮细胞粘附
Corey A Stevens1,2, Boris Sevarika1,3,4, Brian K Wilson5
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Nano letters
|November 21, 2025
概括
研究人员开发了新的避开粘液但粘在细胞上的纳米粒子 (MECS NPs),以改善药物输送. 这些纳米颗粒有效地穿透粘液屏障,并增强与上皮细胞的结合,以获得更好的治疗方法.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 粘液对纳米粒子 (NP) 通过上皮表面传递药物构成重大障碍.
- 粘液捕获纳米粒子,阻碍它们进入目标细胞并限制治疗效果.
研究的目的:
- 为增强粘膜药物递送而设计逃避粘液但仍具有细胞粘性 (MECS) 的纳米颗粒.
- 在纳米粒子设计中克服粘液透和细胞粘附之间的固有权衡.
主要方法:
- 使用闪光纳米沉开发了100纳米MECS纳米粒子.
- 在中性聚乙烯糖醇 (PEG) 冠状体中纳入聚化聚二甲基甲基酸 (PDMAMA).
- 使用体外细胞培养和肠上芯片器官模型评估纳米粒子性能.
主要成果:
- MECS纳米颗粒显示出有效的粘液透,与纯PEGylated对照进行比较.
- 与对照组相比,MECS纳米粒子与上皮细胞的结合率增加了45倍.
- 粘液逃逸和细胞粘附的双重功能在细胞培养和有机体中得到证实.
结论:
- 开发的MECS纳米颗粒为改善穿越粘膜壁垒的药物输送提供了一种多功能战略.
- 这种方法成功地解决了平衡粘膜扩散和细胞吸收的挑战,以提高治疗效果.
- 对于有针对性的药物输送应用来说,MECS纳米颗粒在克服生物障碍方面是一个有希望的进步.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176


